Transfusion-associated graft-versus-host disease
- Yale Univ. School of Medicine, New Haven, CT (USA)
The clinical pathologic syndrome of graft-versus-host disease (GVHD) is usually a sequela of bone marrow transplantation. This disorder occurs as a result of recognition by engrafted donor-derived lymphocytes of foreign recipient transplantation antigens. GVHD may also result from engraftment of lymphocytes from other sources, including (1) transfusion of lymphocytes containing blood components, (2) transplacental maternal fetal transfusion, and (3) passive transfer of lymphocytes in solid organ transplantation. The recipients are usually severely immunodeficient and thus incapable of rejecting the transfused lymphocytes. This syndrome may, however, also develop in immunologically competent patients receiving blood products from individuals with histocompatibility antigens not recognized as foreign. 58 refs.
- OSTI ID:
- 5839612
- Journal Information:
- Yale Journal of Biology and Medicine; (USA), Vol. 63:5; ISSN 0044-0086
- Country of Publication:
- United States
- Language:
- English
Similar Records
Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-versus-host disease, and induction of intolerance
Lethal graft-versus-host disease: modification with allogeneic cultured donor cells
Related Subjects
BLOOD PLATELETS
TRANSFUSIONS
BONE MARROW CELLS
TRANSPLANTS
IMMUNITY
RADIOINDUCTION
BIOLOGICAL RADIATION EFFECTS
DOSE-RESPONSE RELATIONSHIPS
GRAFT-HOST REACTION
LYMPHOCYTES
RISK ASSESSMENT
ULTRAVIOLET RADIATION
ANIMAL CELLS
BIOLOGICAL EFFECTS
BIOLOGICAL MATERIALS
BLOOD
BLOOD CELLS
BODY FLUIDS
CONNECTIVE TISSUE CELLS
ELECTROMAGNETIC RADIATION
LEUKOCYTES
MATERIALS
RADIATION EFFECTS
RADIATIONS
SOMATIC CELLS
THERAPY
560120* - Radiation Effects on Biochemicals
Cells
& Tissue Culture